Back

Efficacy of a parent-child program for 3- to 6-year-old children with stuttering: a retrospective controlled wait-list group study

Neef, N. E.; Niemann, I.; Merkel, A.; Anders, K.; Hente, K.; Joisten, J. M.; Wolff von Gudenberg, A.; Riedel, C. H.

2025-06-20 pediatrics
10.1101/2025.06.20.25329968
Show abstract

We evaluated the efficacy of Frankini, a 12-month early parent-child intervention that combines online parent counseling with hybrid speech restructuring to reduce stuttering severity and promote fluency-supportive interaction. This retrospective, nonrandomized pilot trial included cases enrolled between September 2019 and November 2023. For analysis, only participants who completed Module 1 (indirect parental training) and Module 2 (the first hybrid speech restructuring module) were included. A total of 51 cases met all inclusion criteria, and 30 of these completed all three modules. To simulate a wait-list-controlled design, eligible participants were divided into early and delayed groups using median split. The early group completed Module 2 nine months after baseline, the delayed group twelve months after baseline. Groups were matched on key characteristics and differed only in the timing of the first direct intervention. Blinded raters assessed stuttering severity. Primary outcomes included the Stuttering Severity Index, parental severity rating, and a 10-item parent report. At 9 months, the early group showed reduced stuttering severity, while the delayed group showed no change (mean difference = -8.33 95%CI [-12.98, -3.68], p < 0.001, with d = -1.14). By 12 months, both groups improved, and group difference were no longer significant (mean difference = -3.37 95%CI [-8.23, 1.50], p = 0.168 and d = -0.48). Parental ratings mirrored these outcomes showing consistent improvement after each module. Speech restructuring significantly improved speech fluency and parent counseling enhanced parents confidence, supporting the value of initiating treatment before age 6; however, follow-up is needed to assess long-term effects. Trial RegistrationDRKS00034731.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS ONE
based on 1737 papers
Top 37%
13.4%
2
JAMA Pediatrics
based on 10 papers
Top 0.1%
7.8%
3
The Journal of Pediatrics
based on 15 papers
Top 0.2%
6.5%
4
JAMA Network Open
based on 125 papers
Top 2%
5.4%
5
Pediatric Research
based on 15 papers
Top 0.4%
5.4%
6
BMJ Paediatrics Open
based on 20 papers
Top 1.0%
4.6%
7
Archives of Disease in Childhood
based on 15 papers
Top 0.5%
4.6%
8
BMJ Open
based on 553 papers
Top 28%
3.0%
50% of probability mass above
9
Pediatrics
based on 10 papers
Top 0.3%
2.9%
10
Frontiers in Pediatrics
based on 24 papers
Top 1%
2.5%
11
Journal of Autism and Developmental Disorders
based on 11 papers
Top 0.5%
2.4%
12
Autism Research
based on 14 papers
Top 0.5%
2.4%
13
Psychological Medicine
based on 52 papers
Top 4%
2.4%
14
NeuroImage: Clinical
based on 77 papers
Top 5%
1.8%
15
Scientific Reports
based on 701 papers
Top 68%
1.8%
16
PLOS Medicine
based on 95 papers
Top 8%
1.6%
17
Journal of the American Heart Association
based on 92 papers
Top 9%
1.6%
18
American Journal of Medical Genetics Part A
based on 14 papers
Top 0.9%
1.4%
19
Journal of Clinical Epidemiology
based on 29 papers
Top 1%
1.4%
20
Pediatric Pulmonology
based on 14 papers
Top 1%
1.2%
21
Vaccine
based on 140 papers
Top 4%
1.2%
22
Pilot and Feasibility Studies
based on 12 papers
Top 1%
1.2%
23
Frontiers in Psychiatry
based on 56 papers
Top 7%
0.8%
24
Annals of Neurology
based on 43 papers
Top 5%
0.8%
25
Molecular Autism
based on 11 papers
Top 0.8%
0.8%
26
Medicine
based on 29 papers
Top 9%
0.7%
27
Preventive Medicine Reports
based on 14 papers
Top 2%
0.7%
28
Contemporary Clinical Trials Communications
based on 11 papers
Top 1%
0.7%
29
eClinicalMedicine
based on 55 papers
Top 6%
0.7%